Citations 2
441 | GOLCADOMIDE, A CEREBLON E3 LIGASE MODULATOR (CELMoD) AGENT ± RITUXIMAB, IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: UPDATED PHASE 1/2 RESULTS
Cordoba, R., Perini, Guilherme Fleury , Jørgensen, Judit , Bijou, Fontanet , Munoz, J., Kim, W. S., Rao, P. , Moucheron, Bérengère de, Yang, Gang , Carrancio, Soraya , Sudhindra, Akshay, Voetsch, Jessica, Cordoba, R., Chavez, Julio C , Nastoupil, Loretta J. , Bories, Pierre , Zinzani, Pier Luigi , Munoz, J., Carpio, Cecilia del Carmen , Costa, Alfredo Cardoso , Pourdehnad, Michael , Michot, Jean‐Marie
Hematological Oncology | June 16, 2025 | Volume: 43 | Issue: S3 | Pages: No page available
850 | GOLSEEK‐2: A PHASE 2 RANDOMIZED, OPEN‐LABEL STUDY OF GOLCADOMIDE IN COMBINATION WITH RITUXIMAB IN PARTICIPANTS WITH NEWLY DIAGNOSED ADVANCED‐STAGE FOLLICULAR LYMPHOMA
Perini, Guilherme Fleury , Neto, Abrahão Elias Hallack , Rao, P. , Mikita-Geoffroy, Joanna, Sudhindra, Akshay, Zinzani, Pier Luigi , Villasboas, José C. , Davies, Andrew , Kwiatek, M., Kridel, Robert , Andreadis, Charalambos Babis
Hematological Oncology | June 15, 2025 | Volume: 43 | Issue: S3 | Pages: No page available